Compare OXM & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OXM | YDES |
|---|---|---|
| Founded | 1942 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Apparel | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 675.3M | 543.0M |
| IPO Year | 1994 | N/A |
| Metric | OXM | YDES |
|---|---|---|
| Price | $35.82 | $2.63 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | ★ 579.1K | 33.6K |
| Earning Date | 06-10-2026 | 05-12-2026 |
| Dividend Yield | ★ 6.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | ★ $1,477,834,000.00 | N/A |
| Revenue This Year | $2.85 | N/A |
| Revenue Next Year | $2.63 | N/A |
| P/E Ratio | $38.14 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $30.57 | $2.14 |
| 52 Week High | $51.61 | $25.00 |
| Indicator | OXM | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 36.84 | 32.12 |
| Support Level | $33.84 | N/A |
| Resistance Level | $41.58 | $5.36 |
| Average True Range (ATR) | 2.57 | 0.44 |
| MACD | -0.54 | 0.02 |
| Stochastic Oscillator | 8.28 | 19.51 |
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company's business is organized as: Tommy Bahama, Lilly Pulitzer, Johnny Was and Emerging Brands reportable segments. Geographically, the company operates in United States as well as Internationally.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.